Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Cancer Oncology

Chemistry

Medicine

Immunology

Show all topics

DOI

10.1101/361279

License

CC-BY

Other Formats

PDF